FunPep
4881
Liberta
4935
True Data
4416
AR Advanced Technology
5578
Leoclan
7681
JP Stock MarketDetailed Quotes
4875 MediciNova
- 323
- -14-4.15%
20min DelayNot Open Dec 23 15:30 JST
15.84BMarket Cap-13.47P/E (Static)
336High320Low124.90KVolume336Open337Pre Close40.75MTurnover35452wk High0.30%Turnover Ratio49.05MShares15552wk Low-30.166EPS TTM13.60BFloat Cap1496Historical HighLossP/E (Static)42.09MShs Float129Historical Low-23.974EPS LYR4.75%Amplitude--Dividend TTM1.87P/B100Lot Size--Div YieldTTM
MediciNova Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -48.16%-2.03M | -17.96%-2.81M | -21.74%-3.87M | 42.45%-7.43M | 87.55%-499.06K | 49.58%-1.37M | 2.97%-2.38M | 14.78%-3.18M | -37.63%-12.91M | -10.11%-4.01M |
| Net income from continuing operations | -294.43%-2.85M | 8.48%-2.63M | 5.59%-2.75M | 39.08%-8.57M | 31.40%-2.06M | 80.20%-723.11K | 28.72%-2.87M | 13.85%-2.92M | -38.83%-14.07M | -44.08%-3M |
| Operating gains losses | ---- | ---- | ---- | 266.91%449.38K | --346.49K | --371 | --0 | --102.51K | 42,723.43%122.48K | ---- |
| Depreciation and amortization | -9.17%5.18K | 7.51%5.37K | 30.33%5.35K | 14.62%20.3K | 26.81%5.49K | 27.90%5.7K | 11.30%5K | -7.32%4.11K | -32.28%17.71K | -32.05%4.33K |
| Remuneration paid in stock | 130.38%504.86K | -36.31%207.46K | -46.58%215.43K | 10.61%710.71K | -284.51%-237.41K | 38.44%219.14K | 18.65%325.71K | 397.53%403.26K | -62.59%642.52K | 117.00%128.67K |
| Other non cashItems | -8.36%43.58K | -26.30%36.2K | -0.26%49.39K | -473.04%-151.89K | -236.61%-298.09K | 70.60%47.56K | -12.61%49.12K | 9.61%49.52K | -81.21%40.72K | -265.97%-88.56K |
| Change In working capital | 128.95%266.7K | -496.20%-431.76K | -68.91%-1.38M | -66.48%111.99K | 248.71%1.74M | -224.25%-921.22K | -91.20%108.98K | -73.35%-819.31K | 127.66%334.1K | -36.51%-1.17M |
| -Change in prepaid assets | 23.33%191.68K | -409.15%-395.75K | -77.46%-551.75K | 90.98%287.63K | 57.12%315.11K | 82.07%155.42K | -69.44%128.01K | 43.90%-310.91K | 199.30%150.61K | -64.24%200.55K |
| -Change in payables and accrued expense | 500.17%115.25K | -98.33%507 | -70.14%-781.35K | -94.15%19.24K | 135.82%476.91K | -104.09%-28.8K | -96.40%30.37K | -512.43%-459.25K | 132.05%329.01K | 1.90%-1.33M |
| -Change in other current liabilities | 15.91%-40.23K | 26.10%-36.51K | -3.37%-50.81K | -33.92%-194.88K | -16.01%-48.48K | 0.56%-47.84K | -91.54%-49.41K | -64.80%-49.15K | 37.21%-145.52K | 33.30%-41.79K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -48.16%-2.03M | -17.96%-2.81M | -21.74%-3.87M | 42.45%-7.43M | 87.55%-499.06K | 49.58%-1.37M | 2.97%-2.38M | 14.78%-3.18M | -37.63%-12.91M | -10.11%-4.01M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 107.03%193 | 95.20%-891 | 0 | 199.76%39.91M | 100.00%22 | 99.97%-2.74K | -18.58K | 39.93M | -139,135.03%-40.01M | -30.01M |
| Net PPE purchase and sale | 107.03%193 | ---- | ---- | -325.13%-21.3K | 100.44%22 | ---2.74K | ---- | ---- | 82.56%-5.01K | ---5.01K |
| Net investment purchase and sale | --0 | --0 | --0 | 199.82%39.93M | --0 | --0 | --0 | --39.93M | ---40M | ---30M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 107.03%193 | 95.20%-891 | --0 | 199.76%39.91M | 100.00%22 | 99.97%-2.74K | ---18.58K | --39.93M | -139,135.03%-40.01M | ---30.01M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -99.96%7.92K | 0 | |||||||
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.96%7.92K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.96%7.92K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -16.15%44.34M | -14.70%47.14M | 175.59%51M | -74.09%18.51M | -1.90%51.51M | -18.94%52.88M | -18.37%55.26M | -74.09%18.51M | 18.98%71.43M | -30.01%52.51M |
| Current changes in cash | -47.85%-2.03M | -17.08%-2.81M | -110.53%-3.87M | 161.38%32.48M | 98.53%-499.04K | 89.20%-1.37M | 1.90%-2.4M | 1,085.72%36.75M | -565.43%-52.91M | -844.71%-34.01M |
| Effect of exchange rate changes | -570.83%-25.35K | -41.36%10.85K | 234.58%7.61K | 202.75%17.27K | -186.36%-8.88K | 191.95%5.38K | 232.71%18.5K | 131.13%2.27K | -163.31%-16.81K | 76.19%10.28K |
| End cash Position | -17.91%42.28M | -16.15%44.34M | -14.70%47.14M | 175.59%51M | 175.59%51M | -1.90%51.51M | -18.94%52.88M | -18.37%55.26M | -74.09%18.51M | -74.09%18.51M |
| Free cash from | -47.86%-2.03M | -17.08%-2.81M | -21.74%-3.87M | 42.30%-7.45M | 87.56%-499.04K | 49.48%-1.37M | 2.21%-2.4M | 14.78%-3.18M | -37.26%-12.92M | -10.25%-4.01M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |